Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer

8 Aug 2022

Abstract excerpt

Tumor mutational burden (TMB) has been reported to determine the response to immunotherapy, thus affecting the patient's prognosis in many cancers. However, it is unclear whether TMB or TMB-related signature could be used as prognostic indicators for ovarian cancer (OC), as its potential association with immune infiltration remains poorly understood. Therefore, this study aimed to develop a novel TMB-related risk...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36003381
DOI: 10.3389/fimmu.2022.943389

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancerPMID 36003381Read ↗

Association between tumor mutation burden and immune infiltration in ovarian cancer.Semantic proximity Read ↗

Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.Semantic proximity Read ↗

Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancerSemantic proximity Read ↗

Establishment of a prognostic model based on immune infiltration-related genes and clinical information in ovarian cancerSemantic proximity Read ↗

Robust prognostic model based on immune infiltration-related genes and clinical information in ovarian cancer.Semantic proximity Read ↗

Biological Omics Analysis of Tumor Mutation Burden Combined with Immune Infiltrates in Uterine Corpus Endometrial CarcinomaSemantic proximity Read ↗

Development a prognostic risk model based on B cell-related immune genes in Ovarian Cancer by integrative analysis of single-cell and bulk RNA sequencing dataSemantic proximity Read ↗

Analysis of tumor mutation burden combined with immune infiltrates in endometrial cancerSemantic proximity Read ↗

Single-sample gene set enrichment analysis reveals the clinical implications of immune-related genes in ovarian cancerSemantic proximity Read ↗

Identification of a gene set correlated with immune status in ovarian cancer by transcriptome-wide data miningSemantic proximity Read ↗

Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profilingSemantic proximity Read ↗

The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.